Notice: This company has been marked as potentially delisted and may not be actively trading. Neos Therapeutics (NEOS) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Aytu BioPharma, Inc.: Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial ResultsNovember 13, 2024 | finanznachrichten.deMCET MultiCell Technologies, Inc.October 31, 2024 | seekingalpha.comNEOS/USD - NeosCoin US DollarOctober 18, 2024 | investing.comCara Therapeutics, Inc. (CARA)April 21, 2024 | finance.yahoo.comAvenue Bank wins full APRA licence, bank guarantees in sightMarch 3, 2024 | afr.comPresidio Partners 2007 GP, L.P.'s Net WorthFebruary 9, 2024 | benzinga.comUSAntibiotics Expands Leadership Team with Appointment of Steven Lutz to Vice President of Strategic AccountsDecember 14, 2023 | finance.yahoo.comEledon Pharmaceuticals, Inc.: Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of DirectorsSeptember 11, 2023 | finanznachrichten.deAytu BioPharma, Inc.: Aytu BioPharma Announces Submission of Cotempla XR-ODT Manufacturing Site Transfer Prior Approval SupplementJuly 10, 2023 | finanznachrichten.deAytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval SupplementJuly 10, 2023 | finance.yahoo.comADHD Therapeutics Market Size Worth USD 19740 Million by 2030 at 7.80% CAGR – Report by Market Research Future (MRFR)May 29, 2023 | finance.yahoo.comOverview of Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Dynamics and Trends for 2023-2030May 12, 2023 | marketwatch.comGlobal ADHD Medication Market Analysis and Business Growth Outlook [2023-2030]April 28, 2023 | marketwatch.comAttention Deficit Hyperactivity Disorder (ADHD) Market by Product Type and Consumers-2030April 11, 2023 | marketwatch.comAttention Deficit Hyperactivity Disorder (ADHD) Market 2023 Size and Forecast to 2031April 4, 2023 | marketwatch.comAttention Deficit Hyperactivity Disorder Market to Register a Steady CAGR of 4.40% Between 2023 – 2031 | Growth Plus ReportsApril 3, 2023 | benzinga.comADHD Medication Market 2023 Size and Growth Forecast to 2028March 30, 2023 | marketwatch.com2023 Attention Deficit Hyperactivity Disorder (ADHD) Market: Top Players Best Practices and Sales Forecast 2030March 27, 2023 | marketwatch.comADHD Medication Market Outlook and Forecast till 2030March 24, 2023 | marketwatch.comAttention Deficit Hyperactivity Disorder (ADHD) Market Insights and Forecast to 2028March 21, 2023 | marketwatch.comThis report on ADHD Medication market presents a timeline of technical development and discusses how it affects the market.March 16, 2023 | marketwatch.comADHD Medication Market Analysis, Share by 2028March 14, 2023 | marketwatch.comGlobal Methylphenidate Drug Market Research Covers, Future Trends and Opportunities, Past, Present Data, and Deep Analysis 2030 By VMReportsFebruary 27, 2023 | marketwatch.comChildren Attention Deficit and Hyperactivity Disorder Market 2023: Strategies for Expanding into New Markets across Regions 2029February 19, 2023 | marketwatch.comAttention Deficit Hyperactivity Disorder (ADHD) Market Growth, Business Overview and Forecast to 2028February 15, 2023 | marketwatch.comAvenue Bank aims to free up cash for small businessJanuary 23, 2023 | afr.comNykode Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare ConferenceJanuary 20, 2023 | finance.yahoo.comAttention Deficit Hyperactivity Disorder (ADHD) Market Size 2028 Size Estimation, New Investment Opportunities with Top Countries DataJanuary 11, 2023 | marketwatch.comAttention Deficit and Hyperactivity Disorder Market Analysis Research Report, Challenges, Scopes, Market Share, Revenue, and Forecasts 2022 to 2028October 12, 2022 | marketwatch.comAttention Deficit Hyperactivity Market by Size Estimation, Share Analysis with Recent Developments, Business prospects and Forecast 2022-2031October 2, 2022 | marketwatch.comAytu BioPharma Reports Record Fourth Quarter and Fiscal Year 2022 RevenueSeptember 27, 2022 | ca.finance.yahoo.comAllarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of DirectorsSeptember 26, 2022 | benzinga.comADHD Treatment Market 2022: Industry Growth, Technology Features and Analysis By 2028 with Leading Regions and Countries DataAugust 19, 2022 | marketwatch.comCDB Aviation Executes Sale and Leaseback Transaction with New Middle Eastern Customer Jazeera AirwaysJuly 16, 2022 | finance.yahoo.comAvidbots Neo Cleaning Robot Used by Many of the Newly Named Best Global AirportsJuly 14, 2022 | nz.finance.yahoo.comGlobal Attention Deficit Hyperactivity Disorder (ADHD) Market 2022: Share and Outlook of Regulatory Scenario by 2028June 3, 2022 | marketwatch.comAttention Deficit Hyperactivity Disorder Therapeutics Market 2022-2030 Global Industry Growth Opportunities, Analysis and Regional ForecastMay 25, 2022 | marketwatch.comInsights on the Dental Partnering Global Market - Trends in Dental Dealmaking in the Biopharma Industry Since 2010May 24, 2022 | benzinga.comStimulants Drugs Market Size 2022 by Research Methodology, Value Chain Analysis, Distributors and Forecast to 2029April 27, 2022 | marketwatch.comCobbs Creek Healthcare Hires Global Pharmaceutical Industry Leader Vince Mair as PresidentJanuary 20, 2022 | finance.yahoo.comWho's Hiring In The Columbia Area? See New Local JobsJanuary 18, 2022 | msn.comAltimmune Appoints Richard Eisenstadt As Chief Financial Officer - Quick FactsDecember 13, 2021 | nasdaq.comAltimmune Names Richard Eisenstadt Finance ChiefDecember 13, 2021 | marketwatch.comGlobal Trauma Fixation Device Pipeline Products Market Landscape Report 2021 - ResearchAndMarkets.comDecember 9, 2021 | finance.yahoo.comAytu BioPharma, Inc.: Aytu BioPharma Reports First Quarter 2022 Financial ResultsNovember 15, 2021 | finanznachrichten.deAytu BioPharma, Inc.: Aytu BioPharma Reports Fourth Quarter and Full-Year Fiscal 2021 Financial ResultsSeptember 27, 2021 | finanznachrichten.deImvax Appoints John M. Limongelli as Chief Legal OfficerSeptember 17, 2021 | finance.yahoo.com Get Neos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW NEOS Media Mentions By Week NEOS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEOS News Sentiment▼0.000.60▲Average Medical News Sentiment NEOS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEOS Articles This Week▼00▲NEOS Articles Average Week Get Neos Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DMAC News Today ATAI News Today ACRV News Today ACRS News Today BMEA News Today XBIT News Today VSTM News Today LFVN News Today MGNX News Today SLN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEOS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEOS Stock Alerts